William F. Doyle

2019

In 2019, William F. Doyle earned a total compensation of $8.3M as Executive Chairman at NovoCure, a 82% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$891,000
Option Awards$4,972,114
Salary$750,000
Stock Awards$1,654,987
Other$18,000
Total$8,286,101

Doyle received $5M in option awards, accounting for 60% of the total pay in 2019.

Doyle also received $891K in non-equity incentive plan, $750K in salary, $1.7M in stock awards and $18K in other compensation.

Rankings

In 2019, William F. Doyle's compensation ranked 1,037th out of 13,971 executives tracked by ExecPay. In other words, Doyle earned more than 92.6% of executives.

ClassificationRankingPercentile
All
1,037
out of 13,971
93rd
Division
Manufacturing
354
out of 5,701
94th
Major group
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks
43
out of 832
95th
Industry group
Surgical, Medical, And Dental Instruments And Supplies
24
out of 535
96th
Industry
Surgical and Medical Instruments and Apparatus
12
out of 350
97th
Source: SEC filing on April 27, 2020.

Doyle's colleagues

We found four more compensation records of executives who worked with William F. Doyle at NovoCure in 2019.

2019

Asaf Danziger

NovoCure

Chief Executive Officer

2019

Michael Ambrogi

NovoCure

Chief Operating Officer

2019

Wilhelmus Groenhuysen

NovoCure

Chief Financial Officer

2019

Pritesh Shah

NovoCure

Chief Commercial Officer

News

In-depth

You may also like